FIG 1.
Plasma concentration-time profiles for omadacycline following i.v. (A and B) and oral (C and D) administration in patients with hepatic impairment versus healthy subjects. Data are shown as the mean ± standard deviation. IV, intravenous.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.